The North America cabergoline tablets market is witnessing steady growth as awareness and diagnosis of hyperprolactinemia and associated endocrine disorders increase. Greater access to endocrinology services, established pharmaceutical distribution networks, and continued use of dopamine agonist therapies are supporting regional demand. Growing focus on timely diagnosis and management of...